Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Mifepristone as Adjunctive Therapy in Alzheimer's Disease

ClinicalTrials.gov ID: NCT00105105

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00105105. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 12:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-controlled Trial of the Safety and Efficacy of C-1073 (Mifepristone) as Adjunctive Therapy in Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effects of C-1073 (Mifepristone) on cognition in patients with Alzheimer's disease (AD) who are also taking an acetylcholinesterase inhibitor (Aricept, Exelon or Reminyl).

Study identification

NCT ID
NCT00105105
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Corcept Therapeutics
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2003 (Type not available)
Primary completion
Nov 2005 (Actual)
Completion
Nov 2005 (Actual)
Last update posted
Dec 11, 2009

2003 – 2005

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
20
Facility City State ZIP Site status
Pivotal Research Center Mesa Arizona 85210 —
Pivotal Research Center Peoria Arizona 85381 —
ATP Clinical Trials Fountain Valley California 92708 —
UCI Irvine Medical Center Orange California 92868 —
California Neuroscience Research Medical Group, Inc. Sherman Oaks California 91403 —
AVI Clinical Research Torrance California 90505 —
Baumel-Eisner Neuromed Inst Boca Raton Florida 33486 —
Baumel-Eisner Neuromed Inst Fort Lauderdale Florida 33321 —
Clinical Physiology Associates Fort Myers Florida 33916 —
Baumel-Eisner Neuromed Inst Miami Beach Florida 33154 —
Stedman Clinical Trials Tampa Florida 33613 —
Johnnie B. Byrd, Sr. Alzheimer's Center & Research Inst Tampa Florida 33647 —
Memory Enhancement Center Long Branch New Jersey 07740 —
Eastside Medical Research New York New York 10021 —
Neuro Center of Ohio Toledo Ohio 43623 —
Pahl Pharmaceutical Research, LLC Oklahoma City Oklahoma 73118 —
Clinical Pharmaceutical Trials, Inc. Tulsa Oklahoma 74104 —
Clinical Trials Research Services Pittsburgh Pennsylvania 15206 —
Grayline Clinical Drug Trials Wichita Falls Texas 76309 —
International Clinical Research Associates Richmond Virginia 23229 —
International Clinical Research Associates Virginia Beach Virginia 23452 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00105105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 11, 2009 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.